Bluma Wellness Inc. receives approval for One Plant Florida dispensary and delivery location in Tallahassee and announces RSU grant

“o. itemList. length” “this. config. text. ariaShown”

“This. config. text. ariaFermé”

Bluma Wellness ‘One Plant Florida subsidiary sets up one-day sales on September 10

Bluma Wellness Inc. (the “Company” or “Bluma Wellness”) (CSE: BWEL. U) announces that its wholly owned operating subsidiary, One Plant Florida, has obtained approval from the City of Tallahassee for its retail placement proposal The Company intends to open the One Plant Florida retail store in Tallahassee in the first quarter of 2021 or around that date, with the purpose of obtaining all required regulatory approvals from the City of Tallahassee and the Florida Medical Marijuana Office. Use (“OMMU”).

The One Plant Florida planned location site in Tallhassee is located on the corner of Tennesee and Monroe streets in downtown Tallahassee, allowing the company to care for qualified patients in Tallahassee and Leon County.

“Since I, our president and our legal director are all graduates of Florida State University, we are very proud that our company has won city approval for this location,” said Brady Cobb, CEO of Bluma Wellness. “We look forward to a long association with the network and its patients. “

In addition to the planned opening of its retail store in Tallahassee, Bluma Wellness completes the opening of five (5) one more Plant Florida and/or delivery centers in Ocala, Avon Park, Orlando (Fern Park), North Miami and Bonita Springs through the end of 2020, ending receipt of all required florida OMMU regulatory approvals.

Florida plant releases one-day sales on September 10

In addition, the company is proud to announce that One Plant Florida, on September 10, 2020, achieved a record $111207. 92 in gross revenue in one day at its 4 (4) existing retail and operational dispensaries in Boynton Beach, St. Petersburg, Jacksonville. Beach and Port St. Lucie, Florida, according to the company’s Biotrak/Alleaves Seed Tracking System. The record day of sales comes after the first harvests of dried medicinal hashish flowers from the company’s new crop, processing and laboratory in Indiantown. Florida began reaching One Plant Florida retail outlets in the first week of August.

“The recent record day and continued sales force at One Plant Florida demonstrate our double focus on high-end hash flower medical products and on a scale of guilt,” Cobb said. “With the recent build-up of sources from our Indiantown facility, and through our easy-to-use seed tracking and e-commerce systems for patients, we look to the future to expand our presence of retail clinics and our state-of-the-art network to provide greater service to qualified patients in the state of Florida. “

Bluma Wellness granting RSU

The Company also announces that it has awarded a total of 2,215,000 sets of limited shares (“UAI”) of the company to directors, officers, workers and experts (the “members”), of which 1,841,667 UIIs that were granted are acquired after the rest of UAI are acquired in accordance with the following timetable: a third is acquired after the award; A third party will be acquired on 9 March 2021; and the remaining third will be acquired on 9 March 2022.

THEUS has been awarded to participants in accordance with the terms and subject matter of the situations of the Company’s PSU Plan, which was approved through the Company’s shareholders on April 9, 2020. USRs would possibly be settled in non-unusual money or shares. of the company’s capital, in the sole discretion of the board. All Ordinary Shares issued in accordance with acquired RSU will be subject to an era of inventory exchange retention that will expire 4 months and one day from the date of issuance of the USRs.

RSU beneficiaries come with workers and experts who have provided and continue to supply valuable facilities to One Plant Florida, which has fostered its expansion and expansion in the state.

About Bluma Wellness Inc.

Bluma Wellness Inc. owns and operates an authorized medical hash corporation incorporated vertically in the state of Florida, which operates as “One Plant Florida”. One Plant Florida grows, processes, distributes and sells medical hashish to qualified patients in the state of Florida through several retail dispensaries and a state-of-the-art e-commerce home delivery service the next day, offering convenience to its consumers and meeting the demands of an ever-changing business landscape. Bluma Wellness plans to continue expanding its development and distribution activities as the Florida market expands and can enter other US states. Where the production, distribution and use of hashish is permitted through state law.

Additional Information

The Company’s securities have not been and will not be registered under the U. S. Securities Act. But it’s not the first time And they would probably not be offered or sold in the United States or to a US user. But it’s not the first time In the absence of registration or an applicable exemption from the registration requirement. The press release does not constitute an offer to sell or the request for a purchase offer and there will be no sale of the securities in a jurisdiction where such offer, request or sale would be unlawful.

Prospective information

This press release comprises “forward-looking data” within the meaning of applicable Canadian securities laws, aggregating data related to the opening of the Ocala, Florida dispensary and delivery center at One Plant Florida, in the anticipated opening of more dispensaries and centers. delivery in Florida and the expansion of One Plant Florida’s door-to-door delivery and door-to-door collection network, the planned construction of the plant’s medical hashish production in ‘Indiantown, the integration of the Alleaves platform and corporate strategy business plans. Although the Company believes, despite the delight of its officers and directors, the existing scenario and expected long-term developments and other points deemed appropriate, that the expectations reflected in such forward-looking data are reasonable, they are not. place undue reliance on them because the Company cannot give any guarantee that they will be accurate. Readers are cautioned not to place undue reliance on forward-looking data. The actual effects and developments may possibly differ materially from those considered through such statements due to a variety of known and unknown threats and uncertainties, adding, without limitation: the relevant threats that hashish is illegal under US federal law. US and US federal law threats police movements similar to hashish-like activities; the company’s ability to comply with all applicable government regulations in a highly regulated business; negative adjustments in the political environment or in the regulation of medical hashish in the state of Florida; the threat of business and company operations disruption due to the COVID-19 pandemic; negative adjustments in public opinion and belief in the hash industry and the use of hashish; expanding the festival in the industry; threats of product destruction and other similar security liabilities arising from the use of the Company’s hash products; the company’s limited operating history with no guarantee of loss of profit the ability of the business to access long-term financing when required or on terms appropriate to the business; the threat of default on your existing debt; threat of shortages or rising costs of key inputs, suppliers and professional labor; threats inherent to the functioning of agricultural operations, such as pests and poor harvests; loss of licenses; dependence on key personnel; cybersecurity threats; limitations to the commercialization of products; fraudulent activity through employees, contractors and consultants; tax and insurance threats and litigation threats.

The prospective data contained in this press are as of the date of this pressArray The Company assumes no legal responsibility to update any forward-looking data, unless required by applicable securities laws.

See the edition in businesswire. com: https://www. businesswire. com/news/home/20200915005458/fr/

contacts

For more information about the company: Brady Cobb CEO Phone: (877) 308-3344 Email: Brady@oneplant. us

For media inquiries and investor relations, contact: Daniel Nussbaum AMW PR Telephone: (917) 232-8960 Email: Daniel@amwpr. com

Leave a Comment

Your email address will not be published. Required fields are marked *